[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "US hospital concerns", "description": "US hospitals are under great pressure, there are essentially three reasons for this.\n\nOntario, Canada, largest province in Canada, population of 15 million.\n \nSeveral weeks ago we were told to STOP going for testing unless we were in a high risk category, \n\nso the number of cases is dramatically under-reported, \n \nhttps://toronto.ctvnews.ca/this-is-who-can-and-can-t-get-a-covid-19-test-in-ontario-1.5723794\n \nSo when you see cases dropping in Canada and the R value decreasing, its completely inaccurate, Ontario represents almost half of the popular of the entire country.\n \nSteve\n\nUS hospital pressure\n\nhttps://www.theatlantic.com/health/archive/2022/01/for-covid-with-covid-hospitals-are-mess-either-way/621229/\n\nWith or for covid\n\nJeremy Faust, emergency physician Brigham and Women\u2019s Hospital, Massachusetts\n\nThe truth is, we\u2019re still in the emergency phase of the pandemic,\n\nand everyone who is downplaying that should probably take a tour of a hospital before they do\n\nSara Murray, hospitalist at UC San Francisco\n\nIf a virus that causes less severe lung disease affects an extraordinarily large proportion of the population,\n you\u2019ll still get a lot of them in the hospital with severe lung disease\n\nFactors\n\nLow vaccination uptake\n\nComorbidities\n\nResidual circulation of delta\n\nPost delta infection\n\nOmicron areas, lower hospital admissions\n\nDr. Walensky\n\nI suspect the deaths we are seeing now are still from Delta\n\nJames Lawler, infectious-disease physician, University of Nebraska Medical Center\n\nthe vast majority of our COVID-positive cases are at the hospital for reasons related to their COVID infection\n\nTwo neat categories, with and for\n\nVineet Arora, a hospitalist at the University of Chicago Medicine\n\nIf you\u2019re on the margin of coming into the hospital, COVID tips you over\n\nCOVID might not be listed as a reason for admission, but no COVID, no admission\n\nThese incidental infections are not so incidental for people with chronic conditions\n\nWe have a lot of chronically ill people in the U.S., and it\u2019s like all of those people are now coming into the hospital at the same time\n\nSo, its 3 categories\n\nFor covid\n\nWith covid that exacerbated a chronic condition\n\nTruly incidentals\n\nCraig Spencer, emergency physician, Columbia University Medical Center\n\nThe health-care system is in crisis and on the verge of collapse\n\nIt doesn\u2019t matter whether it\u2019s with or for. It\u2019s a pure deluge of numbers\n\nMr Donald J. Trump\n\nBoosters, politicians who refused to say whether they had received one were \u201cgutless\u201d\n\nThe fact is that I think the vaccines saved tens of millions throughout the world\n\nhttps://www.nytimes.com/live/2022/01/12/world/omicron-covid-testing-vaccines?type=styln-live-updates&label=coronavirus%20updates&index=0#the-white-house-says-it-is-considering-offering-high-quality-masks-to-americans\n\nDysphunc \n \nI've had Covid-19 for 3 days now - 2nd vaccination dose 1 month ago. \n\nIt just feels like a bad case of Pharyngitis. \n\nCongested sinus, gunky sore throat and bronchial tract inflamed. \n\nOccasional painful aspiration but nothing like when I had double Pneumonia. \n\nOximeter reporting 95-98% the whole time so far which is reassuring.", "link": "https://www.youtube.com/watch?v=a1R09yIKqq4", "date_published": "2022-01-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "International data agrees", "description": "Omicron is less severe and natural immunity works\n\nLink to free download of my 2 textbooks\n\nhttp://159.69.48.3/\n\nClinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California \n\nhttps://www.medrxiv.org/content/10.1101/2022.01.11.22269045v1\n\nhttps://www.medrxiv.org/content/10.1101/2022.01.11.22269045v1.full.pdf\n\nBackground\n\nThe Omicron (B.1.1.529) variant of SARS-CoV-2 has rapidly achieved global dissemination,\n\naccounting for most infections in the United States by December 2021. \n\nNovember 30, 2021 to January 1, 2022, Delta v Omicron\n\nUsing S gene target failure (SGTF) (99.7%)\n\nHospital admission\n\nLengths of hospital stay\n\nHospital admissions associated with new-onset respiratory symptoms\n\nIntensive care unit (ICU) admission\n\nMechanical ventilation\n\nMortality\n\nGroup 1, omicron\n\nN =  52,297, cases with Omicron variant infections\n\nHospital admissions, 235 (0.5%)\n\nMean follow-up, 5.5 days\n\n88 admitted\n\nITU, 7\n\nVentilated, 0\n\nDeaths, 1\n\nLength of hospital stay, 3.4 days (70%) less than delta\n\nGroup 2, non \u2013 omicron (delta)\n\nN = 16,982, cases with Delta variant infections\n\nHospital admissions, 222 (1.3%)\n\nMean follow-up, 15.8 days\n\n189 admitted\n\nITU, 23\n\nVentilated, 11\n\nDeaths, 14\n\nAlso\n\nOmicron variant infection, reduced risk of hospitalization across age and comorbidity categories \n\nRisk of symptomatic hospitalization was markedly reduced among cases who had tested positive for SARS-CoV-2 infection \u226590 days prior\n\nIntrinsically less severe infection\n\nLess severe in vaccinated and unvaccinated\n\nEvidence for a reduction in severe outcomes among vaccinated cases with both Delta and Omicron variant infections in our study suggests substantial public health benefits from continued COVID-19 vaccination. \n\nDutch data\n\nhttps://twitter.com/marionkoopmans/status/1472470129350955012\n\nhttps://t.co/TJ6peBST2I\n\nCommon cold protection\n\nhttps://www.imperial.ac.uk/news/233018/cells-from-common-colds-cross-protect-against/\n\nCross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts\n\nhttps://www.nature.com/articles/s41467-021-27674-x.pdf\n\nhttps://www.nature.com/articles/s41467-021-27674-x\n\nCross-reactive immune responses to SARS-CoV-2\n\n52 COVID-19 household contacts\n\nWe enumerate the frequency of specific T cells \n\nSpike, nucleocapsid, membrane, envelope and ORF1,\n\nthat cross-react with human endemic coronaviruses\n\nNucleocapsid-specific T cells\n\nLimited protective function of spike-cross-reactive T cells\n\nOur results are thus consistent with,\n\npre-existing non-spike cross-reactive memory T cells,\n\nprotecting SARS-CoV-2-na\u00efve contacts from infection, \n\nthereby supporting the inclusion of non-spike antigens in second-generation vaccines.", "link": "https://www.youtube.com/watch?v=TrVGymR-jFU", "date_published": "2022-01-12 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]